The impact of TAFI on RSA in specific subgroups.
Similar results were observed in the stratified analysis by age, BMI, PT, PTA, APTT, TT, DD, FT3, FT4, TSH, Anti-Tpo, and Anti-TG. As shown in Figure 2, The correlation between TAFI and the risk of RSA is more significant in participants with age>32, PT>10.9s, PTA≤109%, APTT >32.1s, TT ≤16.2s, DD ≤90ug/ml, FT3>4.42pmol/L, FT4 ≤13.08pmol/L, TSH >1.64uIU/mL, and Anti-TPO negative.